NCT00224393View on ClinicalTrials.gov

Phase II Trial of Enbrel in Patients With Primary Systemic Amyloidosis

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 28, 2001

Study Completion Date

August 31, 2005

Conditions
Primary Systemic Amyloidosis
Interventions
DRUG

Enbrel

All Listed Sponsors
lead

The Cleveland Clinic

OTHER

NCT00224393 - Phase II Trial of Enbrel in Patients With Primary Systemic Amyloidosis | Biotech Hunter | Biotech Hunter